Clinical Trial Update: Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer [NA]

View source ↗

Summary

The clinical trial NCT01018251 evaluating positron emission tomography to monitor treatment response in women with newly diagnosed invasive breast cancer has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment) | NA | Status: WITHDRAWN